Healthcare is increasingly becoming an AI-driven industry, with opportunities spanning the entire value chain—from clinical operations and claims to drug development and patient safety. Yet, unlike many other sectors, healthcare AI operates within a highly regulated environment where accuracy, explainability, data privacy and patient safety are non-negotiable.

This closed-door discussion will examine where AI is already delivering meaningful outcomes across clinical documentation, claims adjudication, pharmacovigilance and clinical trials management, while exploring what it takes to move these use cases from experimentation to responsible enterprise-scale adoption.

The conversation will focus on the practical realities of deploying AI in regulated environments, including model validation, auditability, governance, responsible AI, human-in-the-loop requirements and balancing automation with clinical and business oversight.

The session will bring together senior leaders from the pharma and healthcare ecosystem to exchange experiences, identify proven approaches and discuss how organisations can build the trust and governance required to scale AI responsibly.